Christine Stabell Benn

Christine Stabell Benn
CitizenshipDenmark
EducationUniversity of Copenhagen
Known forResearch on non-specific effects of vaccines
AwardsGeorge Macdonald Medal (2023)
Knight of the Order of the Dannebrog (2025)
Scientific career
FieldsGlobal health, epidemiology, vaccinology
WorkplacesUniversity of Southern Denmark
Bandim Health Project
Danish Institute for Advanced Study

Christine Stabell Benn is a Danish physician, epidemiologist and professor of global health at the University of Southern Denmark. She is chair of the Danish Institute for Advanced Study and has worked with the Bandim Health Project in Guinea-Bissau since 1993.[1] Her research has focused on childhood health interventions, vitamin A supplementation and the proposed non-specific effects of vaccines.[2]

Benn was elected a member of the Academia Europaea in 2020, received the George Macdonald Medal in 2023 and was appointed Knight of the Order of the Dannebrog in 2025.[3][4][5]

Education and career

Benn received her medical degree from the University of Copenhagen in 1996, followed by a PhD in 2003 and a Doctor of Medical Science degree in 2011.[6] She undertook postdoctoral work at Rigshospitalet in Copenhagen and at Stanford University in the United States.[6]

Benn joined the Bandim Health Project as a medical student in 1993. Her early research examined whether vitamin A supplementation influenced the immune response to measles vaccination.[6] She subsequently conducted research into the broader health effects of vaccines and nutritional interventions in Guinea-Bissau and Denmark.

In 2010, Benn received a European Research Council Starting Grant. In 2012, the Danish National Research Foundation selected her to establish and lead the Research Center for Vitamins and Vaccines. She became professor of global health at the University of Southern Denmark in 2013 and chair of the Danish Institute for Advanced Study in 2017.[6][7]

Research

Benn's research has examined whether vaccines and vitamins may affect overall morbidity and mortality in ways that extend beyond their recognised effects on the diseases or deficiencies they are intended to prevent. She has led or participated in randomised trials involving vitamin A supplementation, BCG vaccine, oral polio vaccine and early measles vaccination.[1]

Benn and her collaborators, including Peter Aaby, have argued that some vaccines may produce beneficial or harmful effects against infections unrelated to their intended targets and that these effects may differ between males and females.[8][9] The interpretation, clinical significance and public-health implications of the proposed effects remain debated.[2]

Methodological criticism

A 2025 commentary in the journal Vaccine reviewed randomised trials conducted by the Bandim Health Project. Its authors argued that the reported primary outcomes generally did not substantiate some of the broader claims made about non-specific vaccine effects and raised concerns about outcome reporting, secondary analyses and statistical power.[10]

Benn and Aaby disputed the analysis and asked the journal to retract the commentary. The journal declined the request.[2] In 2026, Science and KFF Health News reported that allegations concerning the reporting of data from earlier trials had been referred by the University of Southern Denmark to Denmark's Board on Research Misconduct. Benn denied that her team had withheld contradictory results and described the criticism of its work as flawed.[11][2]

Proposed hepatitis B vaccine trial

In December 2025, the United States Centers for Disease Control and Prevention awarded approximately US$1.6 million to the University of Southern Denmark for a proposed study of the timing of the hepatitis B vaccine birth dose in Guinea-Bissau. Benn was identified as one of the leaders of the research team.[12]

The proposed randomised trial was intended to enrol approximately 14,000 newborns. One group would receive the vaccine at birth, while the other would follow the country's existing schedule and receive it later. Researchers intended to examine mortality, illness and developmental outcomes.[12]

The study attracted criticism from public-health researchers who argued that withholding the birth dose from some newborns would expose them to preventable infection. The Bandim research team responded that Guinea-Bissau did not routinely administer the vaccine at birth and argued that the study would evaluate the vaccine before the country's planned introduction of a universal birth dose.[12]

In January 2026, the government of Guinea-Bissau suspended the study pending an ethical and technical review after its health minister said that the committee associated with its original approval had not formally met to evaluate it.[13]

The World Health Organization subsequently stated that it had significant concerns about the study's scientific justification, ethical safeguards and compliance with accepted principles for research involving human participants.[14] In March 2026, the University of Southern Denmark said it had paused all work associated with the proposed trial while seeking an independent ethical evaluation. United States health officials stated that the study remained under review and could proceed only after approval from the relevant authorities.[15]

Awards and honours

  • University of Southern Denmark Innovation Prize, 2019[3]
  • Elected member of the Academia Europaea, 2020[3]
  • George Macdonald Medal, awarded by the Royal Society of Tropical Medicine and Hygiene and the London School of Hygiene and Tropical Medicine, 2023[4]
  • Knight of the Order of the Dannebrog, 2025[5]

See also

References

  1. 1 2 "Christine Stabell Benn". University of Southern Denmark. Retrieved 29 July 2026.
  2. 1 2 3 4 Allen, Arthur (18 May 2026). "A Danish Couple's Maverick African Research Finds Its Moment in RFK Jr.'s Vaccine Policy". KFF Health News. Retrieved 29 July 2026.
  3. 1 2 3 "Christine Stabell Benn". Academia Europaea. Retrieved 29 July 2026.
  4. 1 2 "George Macdonald Medal". Royal Society of Tropical Medicine and Hygiene. Retrieved 29 July 2026.
  5. 1 2 "Christine Stabell Benn appointed Knight of the Order of the Dannebrog". University of Southern Denmark. 25 November 2025. Retrieved 29 July 2026.
  6. 1 2 3 4 "Christine Stabell Benn – Biography". Academia Europaea. Retrieved 29 July 2026.
  7. ↑ "Christine Stabell Benn". Danish Institute for Advanced Study. University of Southern Denmark. Retrieved 29 July 2026.
  8. ↑ Benn, Christine Stabell; Netea, Mihai G.; Selin, Liisa K.; Aaby, Peter (September 2013). "A small jab – a big effect: Nonspecific immunomodulation by vaccines". Trends in Immunology. 34 (9): 431–439. doi:10.1016/j.it.2013.04.004. PMID 23680130.
  9. ↑ Aaby, Peter; Benn, Christine Stabell (September 2020). "The non-specific and sex-differential effects of vaccines". Nature Reviews Immunology. 20 (8): 464–470. doi:10.1038/s41577-020-0338-x. PMID 32461691.
  10. ↑ Støvring, Henrik; Ekstrøm, Claus Thorn; Schneider, Jesper Wiborg; Strøm, Charlotte (5 December 2025). "What is actually the emerging evidence about non-specific vaccine effects in randomized trials from the Bandim Health Project?". Vaccine. 68. 127937. doi:10.1016/j.vaccine.2025.127937. PMID 41233263.
  11. ↑ "Controversial Danish vaccine research group faces new allegations". Science. 5 February 2026. Retrieved 29 July 2026.
  12. 1 2 3 Stobbe, Mike (18 December 2025). "US awards no-bid contract to Denmark scientists studying hepatitis B vaccine in African babies". Associated Press. Retrieved 29 July 2026.
  13. ↑ McMakin, Wilson (22 January 2026). "Guinea-Bissau suspends Trump-backed hepatitis B vaccine study for ethical review". Associated Press. Retrieved 29 July 2026.
  14. ↑ "Statement on the planned hepatitis B birth dose vaccine trial in Guinea-Bissau". World Health Organization. 13 February 2026. Retrieved 29 July 2026.
  15. ↑ Schreiber, Melody (11 March 2026). "Experts fear 'unethical' vaccine trial in Africa is 'prototype' for US studies under RFK Jr". The Guardian. Retrieved 29 July 2026.